Related Experiment Video
Updated: Jul 17, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease
Ming-Chang Chiang1, Hui-Mei Chen, Yi-Hsin Lee
1Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei, Taiwan.
Insights
Huntington's disease (HD) involves urea cycle deficiency and ammonia toxicity, worsening neurological symptoms. Protein-restricted diets improved urea cycle function, reduced ammonia, and ameliorated HD symptoms in mouse models.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene.
- Urea cycle deficiency, marked by hyperammonemia, is a significant feature in HD mouse models.
Purpose of the Study:
- To investigate the role of urea cycle deficiency in HD pathogenesis.
- To explore the impact of mutant Huntingtin (Htt) on urea cycle enzyme regulation.
- To evaluate the therapeutic potential of dietary interventions for HD.
Main Methods:
- Utilized two mouse models of Huntington's disease.
- Assessed urea cycle enzyme activity, ammonia levels, and C/EBPalpha transcription factor function.
- Examined the interaction between mutant Htt, C/EBPalpha, and cofactors.
- Investigated the effects of protein-restricted diets on HD pathology and symptoms.
Main Results:
- HD mouse models exhibit urea cycle deficiency and hyperammonemia, potentially exacerbating neurological deficits.
- Mutant Htt impairs C/EBPalpha function by disrupting cofactor interaction and promoting aggregation.
- Protein-restricted diets restored C/EBPalpha activity, repaired urea cycle deficiency, reduced hyperammonemia, and improved motor function and Htt aggregate formation in HD mice.
Conclusions:
- Urea cycle deficiency is a key pathological feature in HD, driven by impaired C/EBPalpha function due to mutant Htt.
- Targeting urea cycle repair and ammonia detoxification presents a promising therapeutic strategy for Huntington's disease.
- Dietary protein restriction demonstrates efficacy in ameliorating HD pathology and symptoms in preclinical models.
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. Using two mouse models of HD, we demonstrate that the urea cycle deficiency characterized by hyperammonemia, high blood citrulline and suppression of urea cycle enzymes is a prominent feature of HD. The resultant ammonia toxicity might exacerbate the neurological deficits of HD. Suppression of C/EBPalpha, a crucial transcription factor for the transcription of urea cycle enzymes, appears to mediate the urea cycle deficiency in HD. We found that in the presence of mutant Htt, C/EBPalpha loses its ability to interact with an important cofactor (CREB-binding protein). Moreover, mutant Htt recruited C/EBPalpha into aggregates, as well as suppressed expression of the C/EBPalpha gene. Consumption of protein-restricted diets not only led to the restoration of C/EBPalpha's activity, and repair of the urea cycle deficiency and hyperammonemia, but also ameliorated the formation of Htt aggregates, the motor deterioration, the suppression of striatal brain-derived neurotrophic factor and the normalization of three protein chaperones (Hsp27, Hsp70 and Hsp90). Treatments aimed at repairing the urea cycle deficiency may provide a new strategy for dealing with HD.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
Urea Cycle
Neural Regulation
Export of Misfolded Proteins out of the ER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

